the Effect of NAFLD on CHB
Conditions
Brief summary
This is a prospective/retrospective, observational follow-up study of effects of fatty liver on chronic hepatitis B. Patients will join this study who undergo transient elastography with liver stiffness (LS) and CAP measurements or Ultrasonic examination. All recruited subjects will undergo comprehensive clinical, anthropometric and laboratory assessments at the time when transient elastography or Ultrasonic examination is performed. We plan to compare the relationship between chronic hepatitis B and non-alcoholic fatty liver disease. Patients will be divided into several groups based on the demand.
Interventions
None listed
Sponsors
Qin Ning
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
age \> 18 years, chronic hepatitis B patients -
Exclusion criteria
patients with chronic hepatitis C or D and human immunodeficiency virus co-infection, excessive alcohol intake (≥30 g/d for men, ≥20 g/d for women), other chronic liver diseases (e.g. primary biliary cholangitis, primary sclerosing cholangitis, autoimmune hepatitis, Wilson's disease), or on medications known to induce hepatic steatosis (including corticosteroids, methotrexate, and tamoxifen), and pregnancy. \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| disease progression | 3 years to 10 years | the effect of NAFLD on CHB |
Countries
China
Contacts
Primary ContactNing Qin, Doctor
Backup ContactMeifang Han, Doctor
Outcome results
None listed